These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25750765)

  • 41. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.
    Wenker TN; Tan MC; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2018 Nov; 63(11):3112-3119. PubMed ID: 30109579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis.
    Li N; Petrick JL; Steck SE; Bradshaw PT; McClain KM; Niehoff NM; Engel LS; Shaheen NJ; Corley DA; Vaughan TL; Gammon MD
    Eur J Epidemiol; 2017 Nov; 32(11):1007-1017. PubMed ID: 28864851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis.
    Zhao Z; Pu Z; Yin Z; Yu P; Hao Y; Wang Q; Guo M; Zhao Q
    Sci Rep; 2016 Jun; 6():27334. PubMed ID: 27256629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett's esophagus.
    Shakhatreh MH; Duan Z; Kramer J; Naik AD; Helm A; Hinojosa-Lindsey M; Chen GJ; El-Serag HB
    Am J Gastroenterol; 2014 Dec; 109(12):1862-8; quiz 1861, 1869. PubMed ID: 25331350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Barrett's esophagus surveillance on the prognosis of esophageal adenocarcinoma: A meta-analysis.
    Ding YE; Li Y; He XK; Sun LM
    J Dig Dis; 2018 Dec; 19(12):737-744. PubMed ID: 30375167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changing epidemiology of esophageal cancer in Finland and the impact of the surveillance of Barrett's esophagus in detecting esophageal adenocarcinoma.
    Voutilainen ME; Juhola MT
    Dis Esophagus; 2005; 18(4):221-5. PubMed ID: 16128777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of surveillance for Barrett's esophagus in Japan and the West.
    Koike T; Saito M; Ohara Y; Hatta W; Masamune A
    DEN Open; 2022 Apr; 2(1):e94. PubMed ID: 35898591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
    Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
    United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoprevention in Barrett's esophagus and esophageal adenocarcinoma.
    Alkhayyat M; Kumar P; Sanaka KO; Thota PN
    Therap Adv Gastroenterol; 2021; 14():17562848211033730. PubMed ID: 34434254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
    Lam S; Hart AR
    Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
    Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
    Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barrett's esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet.
    De Ceglie A; Fisher DA; Filiberti R; Blanchi S; Conio M
    Clin Res Hepatol Gastroenterol; 2011 Jan; 35(1):7-16. PubMed ID: 20970272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurring Translocations in Barrett's Esophageal Adenocarcinoma.
    Bajpai M; Panda A; Birudaraju K; Van Gurp J; Chak A; Das KM; Javidian P; Aviv H
    Front Genet; 2021; 12():674741. PubMed ID: 34178034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.
    Sami SS; Ragunath K; Iyer PG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):623-34. PubMed ID: 24887058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.
    Dulai GS; Guha S; Kahn KL; Gornbein J; Weinstein WM
    Gastroenterology; 2002 Jan; 122(1):26-33. PubMed ID: 11781277
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.